Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 052880/0890 | |
| Pages: | 6 |
| | Recorded: | 06/09/2020 | | |
| Attorney Dkt #: | 37JE-195856-US3_US4 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16895443
|
Filing Dt:
|
06/08/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/24/2020
| | | | |
|
Title:
|
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/08/2021
|
Application #:
|
16895448
|
Filing Dt:
|
06/08/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/24/2020
| | | | |
|
Title:
|
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
|
|
|
Assignee
|
|
|
|
|
| 270 E. GRAND AVE. |
| SUITE 22 |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
Correspondence name and address
|
| |
STEPHANIE LIVA
|
| |
PORTOLA PHARMACEUTICALS, INC.
|
| |
270 E. GRAND AVE, SUITE 22
|
| |
SOUTH SAN FRANCISCO, CA 94080
|
Search Results as of:
04/29/2024 07:59 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
